Member Info for SLF72

Definitely. If I remember correctly the 100 was based on the top academic facilities in the country, because that's where their reach will be. Whereas bracco will have commercial channels into a significant proportion of all pulmonary imaging departments, across various geographies. The opportunity or speed of take up will be exponentially greater.

Hi David,
had they applied for fda approval back then?

If these boards are anything to go by then the value placed on accustem is much higher. So I think they'll do well do avoid quite a big dip in price of Tils come 30th.
Agree though, probably a good thing accustem won't be listed immediately.

3 days notice for a state of emergency. Something of a contradiction in that.

Good to have you on board. this is a very nice place to be.
I bought my last lot on the dip back to 41p. that was only last week i think. looking really good now.

this is great news, but the real value is in the validation and pr this brings. the distribution that polarean can achieve will pale into insignificance compared to what bracco will expect they can manage.
fantastic place to be.

that comparison does make it sound like a stateside listing would apply some real upward pressure on the price Bracco would be inclined to offer.
although with bracco in the wings it does smack of market gamesmanship which our board doesn't seem to take part in and that is something i've considered a professional and commendable quality (until now:))
the board are the best people to value the company, i'll continue to trust them to do the right thing. while keeping fingers crossed that NNOX are put in the shade.

The market cap and earning are related but different.
I think mick is really just saying if the market cap were greater the share price would be greater.
Mick is referring to earnings, hodge the mc which will already be a function of the pe.

Given the market opportunity they elude to. I'm hoping those numbers might turn out to be rather Conservative.

We've talked about this. Everyone's sales spiked but for most it didn't mean incremental sales, just concentration of demand into an earlier period.

The key thing for byotrol is the covid opportunity has turned into medium to long term demand. More contracts, more interest from customers, more product sales (less reliance on one off revenues).
All very good news.

Sorry, I glazed over for a bit then.

Best to buy when they're more expensive, it'll help the upward momentum

Interesting concern over accounting irregularities and repetition of:

revenues around £6m
adj ebitda £250k (yes k)
cash £1.7m

I think this is drawing our attention to the ebitda NOT being 250m (from 6m rev) which would be an eyebrow raising result. The sp maybe up 3x since the arrival of stt1 but let's not get carried away.

"The prime minister's suggestion that this will be as simple as 'getting a pregnancy test' that will give results within 15 minutes is unlikely, if not impossible, in the timescale he was suggesting to get the country back on track."

BBC News - Coronavirus: Concerns over Boris Johnson's 'moonshot' testing plans
https://www.bbc.co.uk/news/uk-54097050

Hopefully Boris does know what he's talking about and it's us.

So, and forgive my ignorance, if that's right does it suggest you can diagnose prior to the condition developing in the first place. That feels a bit scifi.
But amazing if true.

Wow, did not expect to get my money back on these. This year anyway. Happy days. Long live the bubble.

Interesting pyschology in that. How often do you hear anyone say they've spent a load of cash on something cr@p. They don't because they think it makes them look like a douche.

Get something free and it sets you free. You're not invested in the product and youre more likely to be honest.
Obviously some reviewers will be for hire. But consumers are much more aware and cynical of this than they were.

Glad to see you're okay stt1, keep your chin up.

I don't know if it's even possible, but it's beginning to sound like a username change could be on the cards.

Spin, the share price reflects the value the market puts on all this. It may be very wrong but it doesn't matter, because that's the price.

Tils may think stemprinter alone is worth billions, but it doesn't matter until the market agrees and runs the sp up.
Unfortunately, you can't separate the noise of speculation from movements attributed to sustainable market sentiment, so as you've found out there are undulations in the sp.
Hopefully at some point, before or after it's spun out, stemprinter will get the recognition we hope it deserves and its value will reflect the commercial opportunity.

Can you really choose your preference between live prices and wrong prices.